Home / News / $20m in financing for blood-based bowel cancer test

$20m in financing for blood-based bowel cancer test

22 March 2016

Share

Venture capital firm OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer.

Learn More

Share

Subscribe to our Newsletter.

Name

Comments

This field is for validation purposes and should be left unchanged.

$20m in financing for blood-based bowel cancer test

You may also like

Clinical Genomics Announces Nationwide Expansion of Patient Access to COLVERA®

Clinical Genomics Announces Medicare Coverage Applicable to COLVERA® (Liquid Biopsy Test to Detect Recurrence of Colorectal Cancer)

Clinical Genomics announces publication of Additional positive data reinforcing key benefits of COLVERA®

Clinical Genomics expands strategic relationship with Quest Diagnostics and further increases momentum for innovative first-line colorectal cancer screening blood test

Ventured. Gained.

Subscribe to our Newsletter.